A Bubble Fit To Burst? China Genome Testing Firms Soar To New Heights

A company set up five years ago is now worth billions and new funding keeps pouring into the white hot genome testing area in China, despite some observers warning that valuations are unjustified and the bubble is fit to burst.

Cancer-cells-pink-color_1200x675

More from In Vitro Diagnostics

More from Diagnostics